Publications by authors named "A M Jayusman"
Article Synopsis
- Most patients with advanced non-small cell lung cancer (NSCLC) have a poor survival rate, and the study investigates how nutritional status impacts treatment response and overall survival in these patients.
- The study followed 174 patients with stage II-IV NSCLC over two years, revealing that only a small percentage achieved a complete response to treatment, and the median survival was 12 months.
- Findings indicated that being male and overweight or obese are linked to lower survival rates, regardless of other factors like age, disease stage, and baseline health.
Article Synopsis
- - Lung cancer is a leading cause of cancer-related deaths among men, necessitating a biological marker for better treatment outcomes in non-small cell lung cancer (NSCLC) patients, particularly in Indonesia.
- - A retrospective cohort study analyzed various blood test results (e.g., hemoglobin, leukocytes, tumor markers) to assess their impact on the survival rate of NSCLC patients.
- - Significant findings indicated that poor prognostic factors include advanced performance status, late TNM stage, high white blood cell counts, low platelets, and other lab abnormalities, with the need for more research on their correlatives.
Objective: This study aims to evaluate the correlation between electrolytes and serial miRNAs from our previous study. We want to prove that there is the molecular basis that underlying electrolytes disturbances as the predictive indicator to the outcome in NSCLC patients.
Results: There were positive correlation between potassium level with miR-34 (p = 0.
The COVID-pandemic has shown significant impact on cancer care from early detection, management plan to clinical outcomes of cancer patients. The Asian National Cancer Centres Alliance (ANCCA) has put together the 9 "Ps" as guidelines for cancer programs to better prepare for the next pandemic. The 9 "Ps" are Priority, Protocols and Processes, Patients, People, Personal Protective Equipments (PPEs), Pharmaceuticals, Places, Preparedness, and Politics.
View Article and Find Full Text PDFArticle Synopsis
- This study investigates the potential of the FIB-4 index as a predictor of mortality in patients with both hematological malignancies and COVID-19, focusing on finding an optimal cut-off value.
- Conducted at Dharmais National Cancer Hospital in Indonesia, it analyzed 70 patients and found a significant correlation between higher FIB-4 values and increased mortality risk over a 3-month period.
- The results indicated that a FIB-4 index greater than 3.85 had strong predictive power for mortality, with implications for patient management and treatment decisions.